The Social Affairs Commission concluded today its work on Legislative Decree Tomorrow the provision will be completed with the opinion of the other competent commissions. Hard battle over the pharmaceutical handbook which is changed with the PDL amendment. Balduzzi's disappointment, Pd attacks is "the triumph of the lobbies"
10 OCT – The examination of the Balduzzi decree in the Social Affairs Commission of the Chamber ended with a very tough clash between the Pd on one side and the Pdl alliance, Lega Udc on the other. Now the text has been sent to the other competent Commissions (the opinion of the Budget is particularly important, which could reject some of the approved changes) who should send their opinions for tomorrow given that the Minister's decree is expected to be voted in the House on Monday.
There was a very hard clash over article 11, the one relating to the revision of the pharmaceutical handbook and the amendment proposed by the former undersecretary of the Berlusconi government Laura Ravetto ended up under accusation, which essentially eliminates a piece of the Balduzzi decree with the result, from what we learn, that in the Pharmaceutical Handbook that contains the drugs reimbursable by the NHS, there are also medicines destined to end up in range C and which now will not go there.
The Democratic Party has risen up on this point. Anna Miotto group leader in the Commission says that in this way "the formulary and the use of off-label drugs are skipped". The rapporteur takes longer Livia Turkish which defines this amendment as "the triumph of the lobbies".
In short, adds Turco “a very painful page of Parliament has been written. A shameless hustler was made and the parties that voted for her motivated her, including the UDC, with the protection of the citizen's health. But what kind of protection is leaving even those that are not needed in the drug formulary?”.
The minister Balduzzi At the end of the Commission session, he announced that on the drugs chapter his decree had managed to find "a balance" between the protection of the citizen and the desire not to penalize the pharmaceutical industry.
The Minister's goal was to bring the industry "towards goals closer to those of the National Health Service". Moreover, "the set of rules was not intended to penalize the industry but to give greater certainty" for example "on timing and protection of patents &
